The Patent Finder

Factor Bioscience Inc.

63 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Methods and Products for Transfection (US 10,301,599) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 4 fees due Jan 4 to 30, 2027 · next Jan 4
  • 1 fee due Feb 6, 2027
    The maintenance fee for Nucleic Acid Products and Methods of Administration Thereof (US 10,369,233) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
  • 2 fees due Mar 8 to 17, 2027 · next Mar 8
  • 1 fee due Apr 15, 2027
    The maintenance fee for Methods and Products for Transfection (US 10,443,045) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
  • 2 fees due May 12 to 14, 2027 · next May 12
  • 1 fee due Jun 10, 2027
    The maintenance fee for Cationic lipids and transfection methods (US 10,501,404) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 2 fees due Aug 11 to 20, 2027 · next Aug 11
  • 2 fees due Sep 3 to 17, 2027 · next Sep 3
  • 1 fee due Oct 7, 2027
    The maintenance fee for Cationic lipids and transfection methods (US 10,611,722) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,497,124Methods and Products for Reprogramming Cells to a Less Differentiated State
In force
 · High confidence
In forceHigh confidence
US 9,399,761Methods of Reprogramming Cells to a Less Differentiated State
In force
 · High confidence
In forceHigh confidence
US 9,562,218Reprogramming Cells to a Less Differentiated State
In force
 · High confidence
In forceHigh confidence
US 9,695,401Methods and Products for Transfection
In force
 · High confidence
In forceHigh confidence
US 9,879,228Methods and Products for Transfection
In force
 · High confidence
In forceHigh confidence
US 9,969,983Methods and Products for Transfection
In force
 · High confidence
In forceHigh confidence
US 10,131,882Methods and Products for Transfection
In force
 · High confidence
In forceHigh confidence
US 10,301,599Methods and Products for Transfection
In force
 · High confidence
In forceHigh confidence
US 10,443,045Methods and Products for Transfection
In force
 · High confidence
In forceHigh confidence
US 10,472,611Methods and Products for Transfecting Cells
In force
 · Low confidence
In forceLow confidence
10 of 63 patents shown.
Pro members see all 63.
Pro members: see all 63 patents
Also on record, not counted in the 63: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 12 abandoned · 1 no status recorded

Showing 1 to 10 of 18, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/028,477Nucleic Acid-Based TherapeuticsJan 17, 2025Pending
19/028,361Methods and Products for TransfectionJan 17, 2025Pending
18/980,218Methods and Products for Nucleic Acid Production and DeliveryDec 13, 2024Pending
18/480,405Circular RNAOct 3, 2023Abandoned
18/461,368Engineered Immune Cell TherapiesSep 5, 2023Pending
18/328,598Nucleic Acid Products and Methods of Administration ThereofJun 2, 2023Pending
18/046,787Oct 14, 2022No status recorded
17/821,298Methods and Products for Transfecting CellsAug 22, 2022Abandoned
17/820,473Nucleic Acid Products and Methods of Administration ThereofAug 17, 2022Abandoned
17/718,668Methods and Products for Expressing Proteins in CellsApr 12, 2022Abandoned
10 of 18 applications shown.
Pro members see all 18 published applications.
Pro members: see all 18 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited